NewCo Shift Forum 2018
Bill Anderson, CEO of Genetech, on the role of the corporation in the competitive, cutthroat business of drug discovery
While much of this year’s Shift Forum focused on the ever-expanding intersection of technology and politics, investigating the shifting role of business in society also requires we talk about established businesses, in particular those who might teach us lessons we can apply to today’s most pressing issues. In the interview below, the New York Times’ Corner Office columnist David Gelles speaks with Bill Anderson, CEO of life sciences giant Genentech.
John Battelle: We’re here. We’re in San Francisco. We’re in the Valley. We’re in the center of technology. Yes, we’ve heard from a lot of people in tech.
Read More